Relay Therapeutics, Inc.
RLAY
$12.41
-$0.37-2.90%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -33.52% | 25.97% | -5.36% | 8.68% | -1.40% |
| Total Depreciation and Amortization | -15.86% | -19.92% | -25.35% | -17.05% | -9.45% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -20.33% | -17.15% | -7.75% | -9.63% | 15.47% |
| Change in Net Operating Assets | 522.84% | 19.39% | -83.18% | 87.34% | -1,140.79% |
| Cash from Operations | -13.92% | 27.78% | -12.41% | 24.52% | -26.51% |
| Capital Expenditure | -- | -200.00% | 103.85% | 93.23% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -7.23% | -10.72% | -47.16% | 75.43% | 47.77% |
| Cash from Investing | -7.22% | -10.73% | -47.14% | 76.96% | 46.44% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 14,758.89% | 5,394.12% | -97.40% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 14,758.89% | 5,394.12% | -97.40% | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1,523.84% | 62.16% | -208.95% | 166.80% | -9.53% |